Feasibility and Acceptability of Collecting Sociodemographic Data in CCTG Trials
FACTOR
1 other identifier
observational
1,000
1 country
8
Brief Summary
This study is being done to answer the following question: Are patients on a clinical trial willing to provide answers to questions about their social, economic, and environmental factors-sometimes called social determinants of health-which affect people's health experiences and access to care. These factors may include income, education, employment, housing, social supports, and experiences with discrimination or stress. Participation will help researchers better understand barriers to participating in clinical trials and access to health care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2026
8 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 29, 2026
CompletedFirst Posted
Study publicly available on registry
February 5, 2026
CompletedStudy Start
First participant enrolled
May 15, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 30, 2027
July 14, 2026
June 1, 2026
9 months
January 29, 2026
July 13, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
To evaluate the feasibility of collecting comprehensive sociodemographic data via a standardized SDoH Questionnaire among participants being screened and consented to a CCTG trial and participants already enrolled in a CCTG trial
12 months
Secondary Outcomes (1)
To assess the acceptability of this SDoH questionnaire to participants.
12 months
Interventions
This study will use a standardized SDoH Questionnaire to collect the required sociodemographic data
Eligibility Criteria
This study is designed to include participants who have consented to a CCTG clinical trial. If a patient consents to a CCTG trial but does not enroll, they will remain eligible for SC.32S.
You may qualify if:
- Adults (≥18 years) who are either:
- Currently being screened and consented to a CCTG trial (prospective).
- Already enrolled in an ongoing CCTG trial and still under follow-up (retrospective).
You may not qualify if:
- Participants already enrolled or expected to enroll in a CCTG trial that is also collecting the SDoH Questionnaire.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (8)
BCCA - Kelowna
Kelowna, British Columbia, V1Y 5L3, Canada
BCCA - Prince George
Prince George, British Columbia, V2M 7E9, Canada
BCCA - Victoria
Victoria, British Columbia, V8R 6V5, Canada
Regional Health Authority B, Zone 2
Saint John, New Brunswick, E2L 4L2, Canada
Kingston Health Sciences Centre
Kingston, Ontario, K7L 2V7, Canada
CHA-Hopital Du St-Sacrement
Québec, Quebec, G1S 4L8, Canada
Allan Blair Cancer Centre
Regina, Saskatchewan, S4T 7T1, Canada
Saskatoon Cancer Centre
Saskatoon, Saskatchewan, S7N 4H4, Canada
MeSH Terms
Conditions
Study Officials
- STUDY CHAIR
Leah Lambert
BCCA - Vancouver Cancer Centre, Vancouver, BC Canada
- STUDY CHAIR
Michael McKenzie
BCCA - Vancouver Cancer Centre
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- ECOLOGIC OR COMMUNITY
- Time Perspective
- OTHER
- Sponsor Type
- NETWORK
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 29, 2026
First Posted
February 5, 2026
Study Start
May 15, 2026
Primary Completion (Estimated)
January 31, 2027
Study Completion (Estimated)
June 30, 2027
Last Updated
July 14, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will not share